)
Visual
test
Iterum Therapeutics
Iterum Therapeutics (ITRM) investor relations material
Iterum Therapeutics Proxy Filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy Filing summary13 Feb, 2026
Executive summary
Extraordinary general meeting scheduled for February 18, 2026, with four proposals up for shareholder vote.
Board of directors and major proxy advisory firms unanimously recommend voting in favor of all proposals.
Voting is encouraged online or by phone, with a deadline of February 17, 2026, at 11:59 PM ET for remote participation.
Voting matters and shareholder proposals
Four proposals are on the agenda, as detailed in the definitive proxy statement filed January 2, 2026.
Shareholders are urged to vote regardless of the number of shares owned.
Institutional Shareholder Services and Glass Lewis both recommend voting for all proposals.
Board of directors and corporate governance
Board of directors has unanimously recommended approval of all proposals.
Communication to shareholders signed by the President and CEO.
Describe EGM's critical business impact
What factors necessitate urgent shareholder vote?
What is the proxy solicitor's strategic function?
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Iterum Therapeutics
- First FDA-approved oral penem for UUTIs shows strong early adoption and long-term market protection.ITRM
Investor presentation17 Feb 2026 - Q2 net loss narrowed, cash runway extended, and FDA review of sulopenem advances.ITRMQ2 20242 Feb 2026
- Four key proposals up for vote at the February 2026 EGM, with full board support.ITRMProxy Filing26 Jan 2026
- Sulopenem approaches FDA approval as the first oral penem for UTIs, with partnership plans ahead.ITRMMaxim Group’s 2024 Healthcare Virtual Summit19 Jan 2026
- FDA approves Orlynvah, a novel oral penem, for hard-to-treat uUTIs in adult women.ITRMFDA Announcement18 Jan 2026
- Orlynvah gains FDA approval and exclusivity, but urgent funding and strategic action are needed.ITRMQ3 202414 Jan 2026
- ORLYNVAH™ launches as the first oral penem for UUTIs, addressing urgent resistance challenges.ITRMInvestor Presentation3 Jan 2026
- EGM to vote on capital increase, share issuance authority, pre-emption opt-out, and reverse split.ITRMProxy Filing2 Jan 2026
- FDA approval of Orlinva/ORLYNVAH™ and improved financials enable strategic commercialization.ITRMQ4 202424 Dec 2025
Next Iterum Therapeutics earnings date
Q4 20253 Apr, 2026
Iterum Therapeutics
Next Iterum Therapeutics earnings date
Q4 20253 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage